FDA puts full clinical hold on CTI BioPharma's blood cancer drug
February 09, 2016 at 21:42 PM EST
Feb 9 (Reuters) - CTI BioPharma Corp said the U.S Food and Drug Administration has put a full clinical hold on the company's investigational new drug application for pacritinib.
